Pyxis Oncology Ownership | Who Owns Pyxis Oncology?

Overview Forecast RevenueFinancials Chart

Pyxis Oncology Ownership Summary

Pyxis Oncology is owned by 45.02% institutional investors, 23.39% insiders, and 31.60% retail investors. Pfizer is the largest institutional shareholder, holding 11.52% of PYXS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.05% of its assets in Pyxis Oncology shares.

PYXS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Pyxis Oncology	45.02%	23.39%	31.60%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Pfizer	7.03M	11.52%	$7.74M
Laurion capital management lp	3.63M	5.94%	$3.99M
Blackrock	2.79M	5.43%	$9.22M
Millennium management	2.98M	4.91%	$4.65M
Tang capital management	2.50M	4.10%	$2.75M
Vanguard group	2.44M	4.02%	$3.81M
Geode capital management	1.08M	1.78%	$1.69M
Palo alto investors lp	1.04M	1.70%	$1.14M
Blackrock funding, inc. /de	926.80K	1.52%	$1.02M
Abrdn	913.04K	1.50%	$1.00M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Ridgeback capital investments	359.23K	100.00%	$560.40K
Pfizer	7.03M	1.34%	$7.74M
Palo alto investors lp	1.04M	0.24%	$1.14M
Tang capital management	2.50M	0.14%	$2.75M
Schulhoff	275.00K	0.13%	$302.50K
Decheng capital	326.81K	0.09%	$359.49K
Pier 88 investment partners	367.17K	0.08%	$403.89K
Laurion capital management lp	3.63M	0.07%	$3.99M
University of chicago	48.73K	0.05%	$53.60K
683 capital management	545.00K	0.04%	$599.50K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	2.79M	0.00%	2.46M
Tang capital management	2.50M	0.14%	1.40M
Millennium management	2.98M	0.00%	1.07M
State street	742.91K	0.00%	633.55K
Ubs group	446.70K	0.00%	418.60K

Top Sellers

Holder	Shares	% Assets	Change
Deep track capital, lp	-	-	-4.18M
Blackrock funding, inc. /de	926.80K	-	-2.35M
Blue owl capital lp	-	-	-1.13M
Stempoint capital lp	-	-	-850.21K
Ikarian capital	-	-	-613.25K

New Positions

Holder	Shares	% Assets	Change	Value
Ridgeback capital investments	359.23K	100.00%	359.23K	$560.40K
Y-intercept (hong kong)	133.05K	0.00%	133.05K	$146.35K
Hrt financial lp	50.67K	0.00%	50.67K	$55.00K
Aqr capital management	50.08K	0.00%	50.08K	$78.13K
Point72 asia (singapore) pte.	19.23K	0.00%	19.23K	$21.15K

Sold Out

Holder	Change
Ifp advisors	-17.00
West branch capital	-25.00
Nisa investment advisors	-118.00
Capital performance advisors llp	-142.00
Allworth financial lp	-200.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	74	-17.78%	27,483,617	-9.00%	45	1.84%	36	9.09%	23	-14.81%
Mar 31, 2025	91	-9.90%	30,255,964	-4.06%	49	1.84%	35	-42.62%	27	58.82%
Dec 31, 2024	62	-37.37%	11,224,405	-59.75%	18	0.88%	37	-31.48%	10	-33.33%
Sep 30, 2024	99	19.28%	27,885,908	-0.82%	45	1.53%	54	22.73%	15	-37.50%
Jun 30, 2024	83	9.21%	28,117,599	22.50%	54	2.08%	44	-18.52%	24	500.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.27M	2.05%	-27.69K
abrdn Healthcare Investors	626.64K	1.01%	-
Vanguard Institutional Extnd Mkt Idx Tr	537.82K	0.87%	-245.07K
Fidelity Small Cap Index	499.46K	0.81%	-
iShares Russell 2000 Value ETF	464.56K	0.75%	-
abrdn Life Sciences Investors	286.41K	0.46%	-
State St Russell Sm/Mid Cp® Indx SL Cl I	281.69K	0.45%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	281.69K	0.45%	-
iShares Biotechnology ETF	280.21K	0.45%	2.39K
Fidelity Extended Market Index	248.74K	0.40%	-649.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 26, 2024	Connealy Pamela Ann	CFO & COO	Buy	$10.90K
Nov 26, 2024	Connealy Pamela Ann	CFO & COO	Buy	$163.46K
Sep 28, 2023	Connealy Pamela Ann	CFO and COO	Buy	$14.96K
Sep 27, 2023	Wadhane Jitendra	Chief Accounting Officer	Buy	$4.67K
Sep 27, 2023	Connealy Pamela Ann	CFO and COO	Buy	$11.87K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	2	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-

PYXS Ownership FAQ

Who Owns Pyxis Oncology?

Pyxis Oncology shareholders are primarily institutional investors at 45.02%, followed by 23.39% insiders and 31.59% retail investors. The average institutional ownership in Pyxis Oncology's industry, Biotech Stocks , is 306.59%, which Pyxis Oncology falls below.

Who owns the most shares of Pyxis Oncology?

Pyxis Oncology’s largest shareholders are Pfizer (7.03M shares, 11.52%), Laurion capital management lp (3.63M shares, 5.94%), and Blackrock (2.79M shares, 5.43%). Together, they hold 22.89% of Pyxis Oncology’s total shares outstanding.

Does Blackrock own Pyxis Oncology?

Yes, BlackRock owns 5.43% of Pyxis Oncology, totaling 2.79M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 9.22M$. In the last quarter, BlackRock increased its holdings by 2.46M shares, a 766.09% change.

Who is Pyxis Oncology’s biggest shareholder by percentage of total assets invested?

Ridgeback capital investments is Pyxis Oncology’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 359.23K Pyxis Oncology shares, valued at 560.4K$.

Who is the top mutual fund holder of Pyxis Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Pyxis Oncology shares, with 2.05% of its total shares outstanding invested in 1.27M Pyxis Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools